A remarkable aspect of modern medicine is the ever-growing array of medications that fundamentally alter disease trajectories and improve quality of life. At the same time, persistent inequities in access to these medications remain a reality. Pharmacoequity, a term coined in a 2021 article in JAMA,1 is a specific component of health equity focused on fair and just access to appropriate medications, regardless of race, ethnicity, income, insurance coverage, and other social factors.